Wall Street analysts expect Seattle Genetics, Inc. (NASDAQ:SGEN) to announce $254.27 million in sales for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for Seattle Genetics’ earnings, with the lowest sales estimate coming in at $240.73 million and the highest estimate coming in at $268.69 million. Seattle Genetics posted sales of […]
